An official website of the United States Government —

Here’s how you know

Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

GAO makes MedPAC commissioner appointments:

Click here for more information.

Advising the Congress on Medicare issues
MedPAC > Recommendations

Commission Recommendations

MedPAC makes recommendations to the Congress and to the Secretary of Health and Human Services on issues affecting the administration of the Medicare program. With its recommendations, the Commission strives to improve the delivery of care, while ensuring financial stability and maximizing value for the program. After extensive analysis and evaluation, our recommendations are discussed and voted on by Commissioners in our public meetings. Recommendations are typically published in two main reports, released in March and June of each year.

Recommendations Topic(s) Publication

Medicare coverage of clinical pharmacists’ services

The Secretary should assess models for collaborate drug therapy management services in outpatient settings.
  • Drugs, Devices, and Tests

June 2002 - Chapter 3

Paying for new technology in the outpatient prospective payment system (A)

The Congress should: * Replace hospital-specific payments for pass-through devices with national rates. * Give the Secretary authority to consider alternatives to average wholesale price when determining payments for pass-through drugs and biologicals.
  • Drugs, Devices, and Tests
  • Hospital

March 2002 - Chapter 3

Paying for new technology in the outpatient prospective payment system (B)

The Secretary should: * Ensure additional payments are made only for new or substantially improved technologies that are expensive in relation to the applicable ambulatory payment classification payment rate. * Avoid basing national rates only on reported costs. * Ensure that the same broad principles guide payments for new technologies in the inpatient and outpatient… Read more »
  • Drugs, Devices, and Tests

March 2002 - Chapter 3

Accounting for new technology in hospital prospective payment systems (A)

In the outpatient payment system, pass-through payments for specific technologies should be made only when a technology is new or substantially improved and adds substantially to the cost of care in an ambulatory payment classification group.
  • Drugs, Devices, and Tests
  • Hospital

March 2001 - Chapter 3

Accounting for new technology in hospital prospective payment systems (C)

Pass-through payments in the outpatient payment system should be made on a budget-neutral basis and the costs of new or substantially improved technologies should be factored into the update to the outpatient conversion factor.
  • Drugs, Devices, and Tests
  • Hospital

March 2001 - Chapter 3